High Revenue Growth Stocks
Companies with year-over-year revenue growth exceeding 10%, indicating meaningful business expansion.
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
1411 Companies Meeting Criteria
Showing 501–550 of 1411 companies, ranked by Revenue Growth.
| # | Company | Sector | Revenue Growth | Revenue |
|---|---|---|---|---|
| 501 | TELATELA Bio, Inc. | - | 41.1% | - |
| 502 | SMRTSmartRent, Inc. | - | 41.1% | - |
| 503 | BTOCArmlogi Holding Corp. | - | 41.0% | - |
| 504 | DTILPRECISION BIOSCIENCES INC | - | 41.0% | - |
| 505 | FIGFigma, Inc. | Information Technology | 41.0% | - |
| 506 | TLSSTransportation & Logistics Systems, Inc. | - | 40.9% | - |
| 507 | BALLBall Corporation | Materials | 40.8% | $8.6B |
| 508 | LFUSLittelfuse | Information Technology | 40.8% | $1.2B |
| 509 | LEATLeatt Corp | - | 40.6% | - |
| 510 | AEBIAebi Schmidt Holding AG | Industrials | 40.6% | - |
| 511 | CHCIComstock Holding Companies, Inc. | - | 40.6% | - |
| 512 | CFOOChina Foods Holdings Ltd. | - | 40.5% | - |
| 513 | EVLVEvolv Technologies Holdings, Inc. | Information Technology | 40.5% | $104M |
| 514 | HCWCHEALTHY CHOICE WELLNESS CORP. | - | 40.4% | - |
| 515 | SLSNSOLESENCE, INC. | - | 40.4% | - |
| 516 | CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE | Health Care | 40.3% | $1.4B |
| 517 | ONCBeOne Medicines Ltd. | Health Care | 40.2% | $3.8B |
| 518 | ARRYArray Technologies, Inc. | Industrials | 40.2% | $916M |
| 519 | MKZRMacKenzie Realty Capital, Inc. | - | 40.2% | - |
| 520 | LMNDLemonade, Inc. | Financials | 40.2% | $659M |
| 521 | CLMBClimb Global Solutions, Inc. | - | 40.1% | - |
| 522 | CTRACoterra | Energy | 40.1% | $7.1B |
| 523 | WGSGeneDx Holdings Corp. | Health Care | 40.0% | $305M |
| 524 | VISNVistance Networks, Inc. | Information Technology | 39.7% | $4.2B |
| 525 | IGCIGC Pharma, Inc. | - | 39.5% | - |
| 526 | LGCYLegacy Education Inc. | - | 39.5% | - |
| 527 | CDIXCardiff Lexington Corp | - | 39.5% | - |
| 528 | ISSCINNOVATIVE SOLUTIONS & SUPPORT INC | - | 39.4% | - |
| 529 | MELIMERCADOLIBRE INC | Industrials | 39.1% | $20.8B |
| 530 | FVRFrontView REIT, Inc. | - | 39.1% | - |
| 531 | ZYMEZymeworks Inc. | Health Care | 38.9% | $134M |
| 532 | AFRMAffirm Holdings, Inc. | Financials | 38.8% | $3.2B |
| 533 | CECOCECO ENVIRONMENTAL CORP | Industrials | 38.8% | $558M |
| 534 | DUOLDuolingo | Consumer Discretionary | 38.7% | $964M |
| 535 | SNALSnail, Inc. | - | 38.7% | - |
| 536 | TPBTurning Point Brands, Inc. | Consumer Staples | 38.6% | $286M |
| 537 | EVEREverQuote, Inc. | Information Technology | 38.5% | $500M |
| 538 | BBBLACKBERRY Ltd | Information Technology | 38.2% | $535M |
| 539 | MARAMARA Holdings, Inc. | Information Technology | 38.2% | $656M |
| 540 | RKLBRocket Lab Corp | Industrials | 38.0% | $436M |
| 541 | VRDRVERDE RESOURCES, INC. | - | 37.9% | - |
| 542 | ENVXEnovix Corp | Industrials | 37.9% | $23M |
| 543 | GABCGERMAN AMERICAN BANCORP, INC. | Financials | 37.8% | $354M |
| 544 | HALOHalozyme | Health Care | 37.6% | $1.2B |
| 545 | ELAEnvela Corp | - | 37.5% | - |
| 546 | PLXProtalix BioTherapeutics, Inc. | - | 37.5% | - |
| 547 | BEBloom Energy Corp | Industrials | 37.3% | $1.5B |
| 548 | PAYPaymentus Holdings, Inc. | Industrials | 37.3% | $872M |
| 549 | PRCTPROCEPT BioRobotics Corp | Health Care | 37.2% | $224M |
| 550 | LPLALPL Financial Holdings Inc. | Financials | 37.2% | $12.4B |
Understanding Revenue Growth
Revenue growth above 10% is considered strong for large-cap companies. It typically signals increasing demand, successful new products, or geographic expansion. Growth rates are calculated from the two most recent annual SEC filings. One-time events like acquisitions can inflate growth temporarily.
YoY Revenue Growth > 10%
Results are based on SEC EDGAR filings. Companies with missing, unreliable, or extreme outlier values are excluded from screening.
Related Rankings
See the top companies ranked by these related metrics